0.34
price up icon8.80%   0.0275
after-market Handel nachbörslich: .30 -0.04 -11.76%
loading

Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
13.77%
-2.8096
-2.4695 -2.1676 -2.7145 -4.1055
Income/Loss From Continuing Operations Before Tax
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Income/Loss From Continuing Operations After Tax
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Net Income/Loss
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
110.16%
2.4665
-24.27 27.00 26.94 22.77
Diluted Average Shares
110.16%
2.4665
-24.27 27.00 26.94 -2.0708
Basic Earnings Per Share
86.36%
-1.11
-8.14 -0.08 -0.10 -0.18
Diluted Earnings Per Share
86.36%
-1.11
-8.14 -0.08 -0.10 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):